Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Budde

Showing results (91-100 of 3,166) with videos related to

Pageof 317
Sort By:
Applied Optics|March 25, 2010
Compliance of Si photodiodes with Talbot's lawJ Priu, W Budde
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentratesU Budde, E Drewke
Journal of the American Society of Nephrology : JASN|January 27, 2018
Any Progress in the Treatment of Antibody-Mediated Rejection?Klemens Budde, Michael Dürr
International Journal of Pharmaceutics|August 19, 2021
Risk analysis of leachables in cell and gene therapy using a CAR-T model processDana Budde, Elke Jurkiewicz
Hamostaseologie|March 19, 2004
[Classification of von Willebrand disease]R Schneppenheim, U Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Proposal for guidelines for publication of randomized trials in the American Journal of TransplantationKlemens Budde, Lutz Fritsche
Acta Haematologica|January 1, 1995
Alcoholic dyshaematopoiesis: morphological features of alcohol-induced bone marrow damage in biopsy sections compared with aspiration smearsR Budde, U Hellerich
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Hamostaseologie|July 11, 2014
Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpuraU Budde, R Schneppenheim
Pageof 317

Showing results (91-100 of 3,166) with videos related to

Sort By:
Pageof 317
Applied Optics|March 25, 2010
Compliance of Si photodiodes with Talbot's lawJ Priu, W Budde
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentratesU Budde, E Drewke
Journal of the American Society of Nephrology : JASN|January 27, 2018
Any Progress in the Treatment of Antibody-Mediated Rejection?Klemens Budde, Michael Dürr
International Journal of Pharmaceutics|August 19, 2021
Risk analysis of leachables in cell and gene therapy using a CAR-T model processDana Budde, Elke Jurkiewicz
Hamostaseologie|March 19, 2004
[Classification of von Willebrand disease]R Schneppenheim, U Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Proposal for guidelines for publication of randomized trials in the American Journal of TransplantationKlemens Budde, Lutz Fritsche
Acta Haematologica|January 1, 1995
Alcoholic dyshaematopoiesis: morphological features of alcohol-induced bone marrow damage in biopsy sections compared with aspiration smearsR Budde, U Hellerich
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Hamostaseologie|July 11, 2014
Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpuraU Budde, R Schneppenheim
Pageof 317